PHIO 10-Q: SEC filing

Phio Pharmaceuticals Corp.

Filed with the SEC on · accession 0001437749-26-035280

PHIO filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Phio Pharmaceuticals Corp. filed a routine SOX 302 certification signed by President and CEO Robert J. The stock moved -8.0% by the first close after the filing.

Summary of the filing

Phio Pharmaceuticals Corp. filed a routine SOX 302 certification signed by President and CEO Robert J. Bitterman as part of its quarterly Form 10-Q filing. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and internal controls over financial reporting.

Key details

RegistrantPhio Pharmaceuticals Corp.
President and chief executive officerRobert J. Bitterman

How PHIO stock reacted

Close before

$0.87

Nov 4, 2026

First close after

-8.04%

$0.80

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PHIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PHIO?

Click here

Frequently asked questions

What did PHIO file with the SEC on Nov 5, 2026?

PHIO filed a 10-Q (SEC filing). Phio Pharmaceuticals Corp. filed a routine SOX 302 certification signed by President and CEO Robert J. Bitterman as part of its quarterly Form 10-Q filing. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and internal controls over financial reporting.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did PHIO stock react to this filing?

PHIO closed at $0.87 before the filing and $0.80 on Nov 5, 2026 (-8.04%).

Other PHIO SEC filings

Get alerts when PHIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days